Erb's Palsy Clinical Trials

Find Erb's Palsy Clinical Trials Near You

Validity and Reliability of the Turkish Version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The aim of this methodological study is to translate the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ) into Turkish, culturally adapt it, and evaluate its validity and reliability for use in adults with brachial plexus birth palsy. The study will include 50 adult participants aged 18 years and older with a diagnosis of brachial plexus birth palsy. Participants will complete the Turkish version of the IMBPIQ, as well as the Disabilities of the Arm, Shoulder and Hand questionnaire and the Short Form-36. The psychometric properties of the Turkish IMBPIQ will be examined using reliability and validity analyses, including internal consistency, test-retest reliability, and construct validity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Being 18 years of age or older.

• Having a diagnosis of brachial plexus birth palsy.

• Having the ability to read, write, speak, and understand Turkish.

• Agreeing to participate voluntarily in the study and signing the informed consent form.

Locations
Other Locations
Turkey
Biruni University
RECRUITING
Istanbul
Contact Information
Primary
Fahri Dogukan Bozkurt, Physiotherapist, MSc Student
fahrib@biruni.edu.tr
+905392870087
Backup
Zeynep Hosbay, Physiotherapist, Prof.
zhosbay@biruni.edu.tr
+905055034279
Time Frame
Start Date: 2026-08-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 50
Treatments
Adults With Brachial Plexus Birth Palsy
Adults aged 18 years and older with a diagnosis of brachial plexus birth palsy who will complete the Turkish version of the Impact of Brachial Plexus Injury Questionnaire and related assessment tools.
Related Therapeutic Areas
Sponsors
Leads: Biruni University

This content was sourced from clinicaltrials.gov